CBLL1 and colorectal carcinoma: When we analysed the CBLL1 mRNA expression considering the whole cohort of CRC patients (including all CMSs), we found that higher CBLL1 expression was associated with longer OS, further supporting the fact that patients with CMS2 tumours have a good prognosis.